Genomics Study Shows Polygenic Risk Scores Boost Heart Disease Prediction Accuracy

Reuters11-11

Genomics Study Shows Polygenic Risk Scores Boost Heart Disease Prediction Accuracy

IP Group plc has announced new research from Genomics, a science-led techbio company, demonstrating that the addition of polygenic risk scores $(PRS)$ improves the accuracy of the cardiovascular disease (CVD) risk prediction tool PREVENT. The results were presented at the American Heart Association Conference 2025. The study found that integrating PRS into CVD risk prediction tools enhances the identification of individuals at risk of heart disease across different ancestries. According to the research, millions of people currently at high risk of CVD in the U.S. may not be identified using traditional measures that do not include genetic risk. The findings suggest that incorporating PRS into clinical practice could make risk assessment more precise and equitable, potentially improving prevention efforts and outcomes for cardiovascular disease.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IP Group plc published the original content used to generate this news brief on November 10, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2582571243?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-11 18:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2582571243","market":"us","top_or_hot":-1,"title":"Genomics Study Shows Polygenic Risk Scores Boost Heart Disease Prediction Accuracy","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Genomics Study Shows Polygenic Risk Scores Boost Heart Disease Prediction Accuracy\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        IP Group plc has announced new research from Genomics, a science-led techbio company, demonstrating that the addition of polygenic risk scores <a href=\"https://laohu8.com/S/PRS\">$(PRS)$</a> improves the accuracy of the cardiovascular disease (CVD) risk prediction tool PREVENT. The results were presented at the American Heart Association Conference 2025. The study found that integrating PRS into CVD risk prediction tools enhances the identification of individuals at risk of heart disease across different ancestries. According to the research, millions of people currently at high risk of CVD in the U.S. may not be identified using traditional measures that do not include genetic risk. The findings suggest that incorporating PRS into clinical practice could make risk assessment more precise and equitable, potentially improving prevention efforts and outcomes for cardiovascular disease.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IP Group plc published the original content used to generate this news brief on November 10, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Genomics Study Shows Polygenic Risk Scores Boost Heart Disease Prediction Accuracy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenomics Study Shows Polygenic Risk Scores Boost Heart Disease Prediction Accuracy\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-11 18:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Genomics Study Shows Polygenic Risk Scores Boost Heart Disease Prediction Accuracy\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        IP Group plc has announced new research from Genomics, a science-led techbio company, demonstrating that the addition of polygenic risk scores <a href=\"https://laohu8.com/S/PRS\">$(PRS)$</a> improves the accuracy of the cardiovascular disease (CVD) risk prediction tool PREVENT. The results were presented at the American Heart Association Conference 2025. The study found that integrating PRS into CVD risk prediction tools enhances the identification of individuals at risk of heart disease across different ancestries. According to the research, millions of people currently at high risk of CVD in the U.S. may not be identified using traditional measures that do not include genetic risk. The findings suggest that incorporating PRS into clinical practice could make risk assessment more precise and equitable, potentially improving prevention efforts and outcomes for cardiovascular disease.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IP Group plc published the original content used to generate this news brief on November 10, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK5078","symbol_name":"资产管理与托管银行","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDL3YWzSG:1","article_id":"2582571243","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2582571243","pubTimestamp":1762856176,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"IP Group plc has announced new research from Genomics, a science-led techbio company, demonstrating that the addition of polygenic risk scores  improves the accuracy of the cardiovascular disease  risk prediction tool PREVENT. The results were presented at the American Heart Association Conference 2025. The study found that integrating PRS into CVD risk prediction tools enhances the identification of individuals at risk of heart disease across different ancestries. According to the research, millions of people currently at high risk of CVD in the U.S. may not be identified using traditional measures that do not include genetic risk. The findings suggest that incorporating PRS into clinical practice could make risk assessment more precise and equitable, potentially improving prevention efforts and outcomes for cardiovascular disease.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK5078":"资产管理与托管银行","IPO.UK":"IP GROUP"},"translate_title":"基因组学研究显示多基因风险评分可提高心脏病预测准确性","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IPO.UK":0.9},"content_text":"Genomics Study Shows Polygenic Risk Scores Boost Heart Disease Prediction Accuracy\n    \n\n        IP Group plc has announced new research from Genomics, a science-led techbio company, demonstrating that the addition of polygenic risk scores $(PRS)$ improves the accuracy of the cardiovascular disease (CVD) risk prediction tool PREVENT. The results were presented at the American Heart Association Conference 2025. The study found that integrating PRS into CVD risk prediction tools enhances the identification of individuals at risk of heart disease across different ancestries. According to the research, millions of people currently at high risk of CVD in the U.S. may not be identified using traditional measures that do not include genetic risk. The findings suggest that incorporating PRS into clinical practice could make risk assessment more precise and equitable, potentially improving prevention efforts and outcomes for cardiovascular disease.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IP Group plc published the original content used to generate this news brief on November 10, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2582571243","isCrawlerRequest":true}